Literature DB >> 31662348

Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids.

Junji Yamauchi1, Tomoo Sato1, Naoko Yagishita1, Natsumi Araya1, Daisuke Hasegawa1, Shuntaro Tsutsumi2, Misako Nagasaka2,3, Ariella Coler-Reilly2, Eisuke Inoue4, Ayako Takata5, Yasuhiro Hasegawa6, Yoshihisa Yamano7.   

Abstract

Entities:  

Keywords:  HTLV1

Year:  2019        PMID： 31662348     DOI： 10.1136/jnnp-2019-321955

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

Review 1.  Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection.

Authors:  Nicolas Legrand; Skye McGregor; Rowena Bull; Sahar Bajis; Braulio Mark Valencia; Amrita Ronnachit; Lloyd Einsiedel; Antoine Gessain; John Kaldor; Marianne Martinello
Journal:  Clin Microbiol Rev       Date:  2022-02-23       Impact factor: 50.129

2.  Neurofilament Light in CSF and Plasma Is a Marker of Neuronal Damage in HTLV-1-Associated Myelopathy and Correlates With Neuroinflammation.

Authors:  Carolina Rosadas; Henrik Zetterberg; Amanda Heslegrave; Jana Haddow; Mina Borisova; Graham P Taylor
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-10-05

3.  Efficacy of Corticosteroid Therapy for HTLV-1-Associated Myelopathy: A Randomized Controlled Trial (HAMLET-P).

Authors:  Junji Yamauchi; Kenichiro Tanabe; Tomoo Sato; Masanori Nakagawa; Eiji Matsuura; Yoshio Tsuboi; Keiko Tamaki; Hirokuni Sakima; Satoshi Ishihara; Yuki Ohta; Naoki Matsumoto; Kenichi Kono; Naoko Yagishita; Natsumi Araya; Katsunori Takahashi; Yasuo Kunitomo; Misako Nagasaka; Ariella Coler-Reilly; Yasuhiro Hasegawa; Abelardo Araujo; Steven Jacobson; Maria Fernanda Rios Grassi; Bernardo Galvão-Castro; Martin Bland; Graham P Taylor; Fabiola Martin; Yoshihisa Yamano
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

Review 4.  Pathogenesis of HTLV-1 infection and progression biomarkers: An overview.

Authors:  Carlos Brites; Maria Fernanda Grassi; Juarez Antônio Simões Quaresma; Ricardo Ishak; Antonio Carlos Rosário Vallinoto
Journal:  Braz J Infect Dis       Date:  2021-07-10       Impact factor: 3.257
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.